CD19 CAR-T Therapy for Patients With Newly Diagnosed High-risk Large B-cell Lymphoma
Clinical trial NCT04661020 · RECRUITING
Trial details
- NCT number
- NCT04661020
- Sponsor
- Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2026-12-20
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.